“Natural Products and Synthetic Analogs Selectively Modulate NR4A Receptors for Cancer and Inflammatory Diseases Treatment”

https://pubmed.ncbi.nlm.nih.gov/38116863

Natural products and synthetic analogs can selectively modulate orphan nuclear receptor 4A (NR4A) members, which have potential as drug targets for cancer and inflammatory diseases.